Could Simcere’s Stanford Medicine IPF deal expose the next big gap in fibrosis treatment?
Find out how Simcere and Stanford Medicine’s IPF collaboration could reshape early-stage antifibrotic drug discovery.
Can Mevion’s S250-FIT make proton therapy practical for more cancer centers?
Proton therapy has long had an infrastructure problem. Mevion’s S250-FIT asks whether existing LINAC vaults can change that.